Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
May 1st, 2018
This protocol describes a detailed procedure for the construction of a phage-displayed synthetic antibody library with tailored diversity. Synthetic antibodies have broad applications from basic research to disease diagnostics and therapeutics.
The overall goal of this procedure is to provide readers detailed hands-on experience in constructing a phage displayed synthetic human antibody library with tailored diversity. Synthetic phage displayed antibody libraries have great potential for replace traditionally hybridoma-based techniques for therapeutic monoclonal antibody development by bypassing the need for animal immunization and the subsequent antibody humanization. The advantage of synthetic antibody library is that tailored diversity is introduced into an antibody framework using insight into positional diversity that support high affinity interaction and desirable protein properties.
Beyond the practical utility, synthetic antibody libraries can also be used to experimentally probe the role of specific amino acids in biomolecular interactions, thus supporting their own continuous improvement. This procedure will be demonstrated by graduate student named Zhenwei Zhong and Doctor Shin-chen Hou from our laboratory. To be
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol provides a detailed procedure for constructing a phage-displayed synthetic antibody library with tailored diversity. Such libraries have the potential to replace traditional hybridoma-based techniques for therapeutic monoclonal antibody development.
Key Study Components
Area of Science
- Neuroscience
- Biotechnology
- Immunology
Background
- Synthetic antibodies can be engineered to have specific properties.
- Phage display technology allows for the selection of high-affinity antibodies.
- Traditional methods involve animal immunization, which this protocol aims to bypass.
- Tailored diversity enhances the potential for effective therapeutic applications.
Purpose of Study
- To provide hands-on experience in antibody library construction.
- To demonstrate the advantages of synthetic libraries over traditional methods.
- To explore the role of specific amino acids in biomolecular interactions.
Methods Used
- Construction of a synthetic human antibody library.
- Phage display techniques for antibody selection.
- Analysis of antibody interactions and properties.
- Demonstration by graduate students and faculty.
Main Results
- Successful construction of a synthetic antibody library.
- Demonstration of high-affinity interactions through tailored diversity.
- Insights into the role of amino acids in antibody functionality.
- Potential applications in diagnostics and therapeutics.
Conclusions
- Synthetic antibody libraries offer a promising alternative to traditional methods.
- Tailored diversity can lead to improved antibody properties.
- Further research can enhance the utility of synthetic libraries in various applications.
Frequently Asked Questions
Executive Industry Relevance
Synthetic phage-displayed Fab libraries enable target-agnostic antibody discovery by introducing tailored diversity into human antibody frameworks, reducing reliance on animal immunization and accelerating therapeutic candidate identification. This approach supports early-stage target validation by providing high-diversity libraries for screening against disease-relevant antigens, improving hit rates and de-risking lead selection. The method enhances predictive confidence in antibody functionality through controlled diversification of complementarity-determining regions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by screening diverse Fab variants against targets of interest.
- Operational Value: Provides a non-animal-based platform for antibody generation, eliminating immunization timelines and humanization bottlenecks.
- Predictive Value: Tailored diversity based on positional insights increases likelihood of isolating high-affinity, developable candidates.
Screening & Assay Development
- Scientific Value: Generates phage-displayed Fab libraries with quantified diversity (10^9–10^10) for robust panning campaigns.
- Operational Value: Standardized library construction via electroporation and Kunkel mutagenesis ensures batch-to-batch reproducibility.
- Assay Readiness: Protein A/L-based ELISA enables functional evaluation of folded Fab fragments post-selection.
Translational & Preclinical Research
- Translational Continuity: Supports progression from hit identification to lead optimization using sequence-verified Fab clones.
- Mechanistic De-risking: Facilitates probing of amino acid contributions to binding and stability, informing developability assessments.
- Preclinical Relevance: Enables generation of human-derived Fab fragments suitable for downstream Fc engineering and format conversion.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, supporting library generation for panning against purified antigens or cellular targets, followed by ELISA-based screening and sequencing for lead identification.
- Discovery Biology: Enables hypothesis-driven exploration of antibody-target interactions through controlled mutagenesis of CDR loops.
- Screening: Produces phage-displayed libraries compatible with standard panning protocols against immobilized or soluble antigens.
- Analytics: DNA sequence analysis of library diversity informs enrichment tracking and clonal evolution during selection rounds.
- Translational Research: Outputs sequence-confirmed Fab fragments suitable for expression, purification, and biophysical characterization.
- Enterprise Reuse: Electroporation-based library construction is scalable and adaptable to multiple antibody frameworks and target classes.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in antibody-target interactions by enabling systematic diversity exploration.
- Operational Value: High-efficiency electro-competent cells and standardized mutagenesis ensure library quality and reproducibility.
- Strategic Value: Accelerates lead identification by increasing probability of isolating functional, high-affinity binders early in discovery.
- Portfolio Impact: Supports risk-adjusted prioritization through diverse, sequence-validated libraries that improve attrition profiles.
Implementation Considerations
- Requires expertise in molecular biology, phage handling, and ELISA-based functional screening.
- Dependent on electroporation efficiency and uracil-containing ssDNA extraction for mutagenesis efficiency.
- Necessitates standardization of protein A/L-based ELISA conditions across teams for consistent folding assessment.
- Adaptable to various human antibody frameworks but requires framework-specific optimization of mutagenesis sites.
- Library diversity assessment via DNA sequencing is essential to confirm theoretical diversity is achieved post-electroporation.
Biopharma FAQs
Chapters in this video
0:04
Title
1:18
Electroporation and Calculation of the Library Size
6:02
Quality Assessment by Protein A/L Direct Binding ELISA Assay and Sequencing
9:43
Results: Conversion of dU-ssDNA to CCC-DNA and Phage Titration for Calculation of Library Size
11:07
Conclusion
